Display Settings:

Format

Send to:

Choose Destination
    Eur J Cancer. 2000 Sep;36 Suppl 4:S34-5.

    Modulation of oestrogen action by receptor gene inhibition.

    Source

    Tenovus Cancer Research Centre, Welsh School of Pharmacy, Redwood Building, King Edward VII Ave, CF10 3XE, Cardiff, UK. maddenta1@cardiff.ac.uk

    Abstract

    Selective oestrogen receptor downregulators (SERDs) are a class of highly effective steroidal antitumour agents that reduce cellular levels of the oestrogen receptor (ER). In this study, we compared the efficacy by which three novel molecular approaches: (1) antisense oligonucleotides; (2) antisense RNA; and (3) dominant negative mutants are able to act as SERDs. Using transient and, where appropriate, stable gene transfection experiments we found that constitutive overexpression of ER antisense RNA and a hormone-binding domain compromised dominant-negative ER mutant (DNER-1), were most effective at downregulating ER expression and/or activity in vitro.

    PMID:
    11056309
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk